Works in Clinical Pharmacology & Therapeutics, 2001, Vol 70, Issue 5

Results: 15

Effect of gemfibrozil on the pharmacokinetics and pharmacodynamics of glimepiride*.

Published in:

Clinical Pharmacology & Therapeutics, 2001, v. 70, n. 5, p. 439, doi. 10.1016/S0009-9236(01)84578-1

By:

Niemi, Mikko;
Neuvonen, Pertti J.;
Kivistö, Kari T.

Publication type:

Article

Fluvoxamine-theophylline interaction: Gap between in vitro and in vivo inhibition constants toward cytochrome P4501A2*.

Published in:

Clinical Pharmacology & Therapeutics, 2001, v. 70, n. 5, p. 415, doi. 10.1016/S0009-9236(01)62844-3

By:

Yao, Caiping;
Kunze, Kent L.;
Kharasch, Evan D.;
Wang, Yi;
Trager, William F.;
Ragueneau, Isabelle;
Levy, René H.

Publication type:

Article

Influence of hepatic impairment on everolimus pharmacokinetics: Implications for dose adjustment.

Published in:

Clinical Pharmacology & Therapeutics, 2001, v. 70, n. 5, p. 425, doi. 10.1016/S0009-9236(01)15633-X

By:

Kovarik, John M.;
Sabia, Helene D.;
Figueiredo, Joaquim;
Zimmermann, Heidrun;
Reynolds, Christine;
Dilzer, Stacy C.;
Lasseter, Kenneth;
Rordorf, Christiane

Publication type:

Article

Stereoselective pharmacokinetics of ketamine: R(−)-Ketamine inhibits the elimination of S(+)-ketamine*.

Published in:

Clinical Pharmacology & Therapeutics, 2001, v. 70, n. 5, p. 431, doi. 10.1016/S0009-9236(01)06321-4

By:

Ihmsen, Harald;
Geisslinger, Gerd;
Schüttler, Jürgen

Publication type:

Article

Ritonavir increases loperamide plasma concentrations without evidence for P-glycoprotein involvement*.

Published in:

Clinical Pharmacology & Therapeutics, 2001, v. 70, n. 5, p. 405, doi. 10.1016/S0009-9236(01)35864-2

By:

Tayrouz, Yorki;
Ganssmann, Beate;
Ding, Reinhard;
Klingmann, Andrea;
Aderjan, Rolf;
Burhenne, Jürgen;
Haefeli, Walter Emil;
Mikus, Gerd

Publication type:

Article

Early postoperative erythromycin breath test correlates with hepatic cytochrome P4503A activity in liver transplant recipients*.

Published in:

Clinical Pharmacology & Therapeutics, 2001, v. 70, n. 5, p. 446, doi. 10.1016/S0009-9236(01)36203-3

By:

Schmidt, Lars E.;
Olsen, Anette Kristensen;
Stentoft, Karen;
Rasmussen, Allan;
Kirkegaard, Preben;
Dalhoff, Kim

Publication type:

Article

Assessment of cytochrome P450 activity by a five-drug cocktail approach*.

Published in:

Clinical Pharmacology & Therapeutics, 2001, v. 70, n. 5, p. 455, doi. 10.1016/S0009-9236(01)92726-2

By:

Zhu, Bing;
Ou-Yang, Dong-Sheng;
Chen, Xiao-Ping;
Huang, Song-Lin;
Tan, Zhi-Rong;
He, Nan;
Zhou, Hong-Hao

Publication type:

Article

Red wine decreases cyclosporine bioavailability*.

Published in:

Clinical Pharmacology & Therapeutics, 2001, v. 70, n. 5, p. 462, doi. 10.1016/S0009-9236(01)70992-7

By:

Tsunoda, Shirley M.;
Harris, Robert Z.;
Christians, Uwe;
Velez, Rebecca L.;
Freeman, Richard B.;
Benet, Leslie Z.;
Warshaw, Abigail

Publication type:

Article

Low sodium and furosemide-induced stimulation of the renin system in man is mediated by cyclooxygenase 2.

Published in:

Clinical Pharmacology & Therapeutics, 2001, v. 70, n. 5, p. 468, doi. 10.1016/S0009-9236(01)49789-X

By:

Kammerl, Martin C.;
Nüsing, Rolf M.;
Schweda, Frank;
Endemann, Dierk;
Stubanus, Mike;
Kees, Frieder;
Lackner, Karl J.;
Fischereder, Michael;
Krämer, Bernhard K.

Publication type:

Article

The human pharmacology of monocyte cyclooxygenase 2 inhibition by cortisol and synthetic glucocorticoids*.

Published in:

Clinical Pharmacology & Therapeutics, 2001, v. 70, n. 5, p. 475, doi. 10.1016/S0009-9236(01)14130-5

By:

Santini, Giovanna;
Patrignani, Paola;
Sciulli, Maria G.;
Seta, Francesca;
Tacconelli, Stefania;
Panara, Maria R.;
Ricciotti, Emanuela;
Capone, Marta L.;
Patrono, Carlo

Publication type:

Article

Effect of high-dose lansoprazole on intragastic pH in subjects who are homozygous extensive metabolizers of cytochrome P4502C19*.

Published in:

Clinical Pharmacology & Therapeutics, 2001, v. 70, n. 5, p. 484, doi. 10.1016/S0009-9236(01)28055-2

By:

Furuta, Takahisa;
Shirai, Naohito;
Xiao, Fang;
Ohashi, Kyoichi;
Ishizaki, Takashi

Publication type:

Article

Limited sampling approach.

Published in:

Clinical Pharmacology & Therapeutics, 2001, v. 70, n. 5, p. 493, doi. 10.1016/S0009-9236(01)90137-7

By:

Duvaldestin, Philippe

Publication type:

Article

Reply.

Published in:

Clinical Pharmacology & Therapeutics, 2001, v. 70, n. 5, p. 493, doi. 10.1016/S0009-9236(01)90138-9

By:

Penson, Richard T.;
Joel, Simon P.

Publication type:

Article

A MESSAGE FROM THE ASCPT MEMBERSHIP COMMITTEE CHAIR.

Published in:

Clinical Pharmacology & Therapeutics, 2001, v. 70, n. 5, p. 495, doi. 10.1016/S0009-9236(01)72611-2

By:

Kroetz, Deanna L.

Publication type:

Article

List no. 443 New Names.

Published in:: Clinical Pharmacology & Therapeutics, 2001, v. 70, n. 5, p. 496, doi. 10.1016/S0009-9236(01)90139-0
Publication type:: Article

Works in Clinical Pharmacology & Therapeutics, 2001, Vol 70, Issue 5

Effect of gemfibrozil on the pharmacokinetics and pharmacodynamics of glimepiride<sup>*</sup>.

Fluvoxamine-theophylline interaction: Gap between in vitro and in vivo inhibition constants toward cytochrome P4501A2<sup>*</sup>.

Influence of hepatic impairment on everolimus pharmacokinetics: Implications for dose adjustment.

Stereoselective pharmacokinetics of ketamine: R(−)-Ketamine inhibits the elimination of S(+)-ketamine<sup>*</sup>.

Ritonavir increases loperamide plasma concentrations without evidence for P-glycoprotein involvement<sup>*</sup>.

Early postoperative erythromycin breath test correlates with hepatic cytochrome P4503A activity in liver transplant recipients<sup>*</sup>.

Assessment of cytochrome P450 activity by a five-drug cocktail approach<sup>*</sup>.

Red wine decreases cyclosporine bioavailability<sup>*</sup>.

Low sodium and furosemide-induced stimulation of the renin system in man is mediated by cyclooxygenase 2.

The human pharmacology of monocyte cyclooxygenase 2 inhibition by cortisol and synthetic glucocorticoids<sup>*</sup>.

Effect of high-dose lansoprazole on intragastic pH in subjects who are homozygous extensive metabolizers of cytochrome P4502C19<sup>*</sup>.

Limited sampling approach.

Reply.

A MESSAGE FROM THE ASCPT MEMBERSHIP COMMITTEE CHAIR.

List no. 443 New Names.